JLE

Epileptic Disorders

MENU

LGI-1 antibody encephalitis in a seven-year-old girl Volume 21, issue 6, December 2019

  • [Gadoth et al., 2017] Gadoth A., Pittock S.J., Dubey D. Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients. Ann Neurol. 2017;82:79-92.
  • [Gastaldi et al., 2016] Gastaldi M., Thouin A., Vincent A. Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics. 2016;13:147-162. 1
  • [Goveas et al., 2011] Goveas J.S., Xie C., Ward B.D. Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI. J Magn Reson Imaging. 2011;34:764-773. 4
  • [Janas-Kozik et al., 2017] Janas-Kozik M., Krzystanek M., Cichoń L. An adolescent case of limbic encephalitis with anti leucine rich glioma inactivated 1 antibodies. Neuropsychiatry. 2017;7:179-182. 2
  • [Kegel et al., 2013] Kegel L., Aunin E., Meijer D., Bermingham J.R. LGI proteins in the nervous system. ASN Neuro. 2013;5:167-181.
  • [Kuba et al., 2010] Kuba R., Musilová K., Brázdil M., Rektor I. Peri-ictal yawning lateralizes the seizure onset zone to the nondominant hemisphere in patients with temporal lobe epilepsy. Epilepsy Behav. 2010;19:311-314.
  • [Leutmezer et al., 1998] Leutmezer F., Serles W., Lehrner J., Pataraia E., Zeiler K., Baumgartner C. Postictal nose wiping: a lateralizing sign in temporal lobe complex partial seizures. Neurology. 1998;51:1175-1177. 4
  • [Li et al., 2018a] Li W., Wu S., Meng Q. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurology. 2018;18:96.
  • [Li et al., 2018b] Li L.-H., Ma C.-C., Zhang H.-F., Lian Y.-J. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis. Epilepsy Behav. 2018;88:277-282.
  • [López-Chiriboga et al., 2018] López-Chiriboga A.S., Klein C., Zekeridou A. LGI1 and CASPR2 neurological autoimmunity in children. Ann Neurol. 2018;84:473-480.
  • [Manna et al., 2014] Manna I., Mumoli L., Labate A. Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene. Epilepsy Res. 2014;108:597-599. 3
  • [Sanger et al., 2010] Sanger T.D., Chen D., Fehlings D.L. Definition and classification of hyperkinetic movements in childhood. Mov Disord. 2010;25:1538-1549.
  • [Steriade et al., 2018] Steriade C., Moosa A.N.V., Hantus S., Prayson R.A., Alexopoulos A., Rae-Grant A. Electroclinical features of seizures associated with autoimmune encephalitis. Seizure. 2018;60:198-204.
  • [Tufenkjian and Lüders, 2012] Tufenkjian K., Lüders H.O. Seizure semiology: its value and limitations in localizing the epileptogenic zone. J Clin Neurol. 2012;8:243-250.
  • [Van Sonderen et al., 2016] Van Sonderen A., Thijs R.D., Coenders E.C. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016;87:1449-1456.
  • [Vincent et al., 2004] Vincent A., Buckley C., Schott J.M. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127:701-712. 3
  • [Vives-Rodriguez et al., 2017] Vives-Rodriguez A., Sivaraju A., Louis E.D. Drop attacks: a clinical manifestation of LGI1 encephalitis. Neurol Clin Pract. 2017;7:442-443. 5
  • [Wang et al., 2017] Wang M., Cao X., Liu Q., Ma W., Guo X., Liu X. Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat. 2017;13:1589-1596.